These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 27871026

  • 21. Copeptin under glucagon stimulation.
    Lewandowski KC, Lewiński A, Skowrońska-Jóźwiak E, Stasiak M, Horzelski W, Brabant G.
    Endocrine; 2016 May; 52(2):344-51. PubMed ID: 26578365
    [Abstract] [Full Text] [Related]

  • 22. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [Abstract] [Full Text] [Related]

  • 23. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K, Jahn H, Yassouridis A, Kellner M.
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [Abstract] [Full Text] [Related]

  • 24. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
    Goettel M, Fuertig R, Mack SR, Just S, Sharma V, Wunder A, den Boer J.
    CNS Drugs; 2023 Dec; 37(12):1099-1109. PubMed ID: 38019356
    [Abstract] [Full Text] [Related]

  • 25. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [Abstract] [Full Text] [Related]

  • 26. Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.
    Flint AJ, Koszycki D, Bradwejn J, Vaccarino FJ.
    Psychoneuroendocrinology; 2000 Aug; 25(6):633-47. PubMed ID: 10840174
    [Abstract] [Full Text] [Related]

  • 27. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC, Johnson EO, Calogero AE, Kalogeras KT, Bernardini R, Chrousos GP, Gold PW.
    Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423
    [Abstract] [Full Text] [Related]

  • 28. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
    Otte C, Moritz S, Yassouridis A, Koop M, Madrischewski AM, Wiedemann K, Kellner M.
    Neuropsychopharmacology; 2007 Jan; 32(1):232-8. PubMed ID: 17035932
    [Abstract] [Full Text] [Related]

  • 29. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D, Zacharko RM, Le Mellédo JM, Bradwejn J.
    Depress Anxiety; 1998 Jan; 8(1):1-7. PubMed ID: 9750972
    [Abstract] [Full Text] [Related]

  • 30. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin.
    Abelson JL, Liberzon I.
    Neuropsychopharmacology; 1999 Oct; 21(4):485-94. PubMed ID: 10481831
    [Abstract] [Full Text] [Related]

  • 31. Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress.
    Kacheva S, Kolk K, Morgenthaler NG, Brabant G, Karges W.
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):570-6. PubMed ID: 25200793
    [Abstract] [Full Text] [Related]

  • 32. Dose response of arginine vasopressin to the CCK-B agonist pentagastrin.
    Abelson JL, Le Mellédo J, Bichet DG.
    Neuropsychopharmacology; 2001 Feb; 24(2):161-9. PubMed ID: 11120398
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.
    Eser D, Schüle C, Baghai T, Floesser A, Krebs-Brown A, Enunwa M, de la Motte S, Engel R, Kucher K, Rupprecht R.
    Psychopharmacology (Berl); 2007 Jul; 192(4):479-87. PubMed ID: 17318504
    [Abstract] [Full Text] [Related]

  • 34. Responses induced by arginine-vasopressin injection in the plasma concentrations of adrenocorticotropic hormone, cortisol, growth hormone and metabolites around weaning time in goats.
    Katoh K, Yoshida M, Kobayashi Y, Onodera M, Kogusa K, Obara Y.
    J Endocrinol; 2005 Nov; 187(2):249-56. PubMed ID: 16293772
    [Abstract] [Full Text] [Related]

  • 35. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL, Irvine CH, Livesey JH, Donald RA.
    Endocrinology; 1993 Aug; 133(2):860-6. PubMed ID: 8393777
    [Abstract] [Full Text] [Related]

  • 36. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
    Grottoli S, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, DeStefanis S, Camanni F, Ghigo E, Arvat E.
    J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
    [Abstract] [Full Text] [Related]

  • 37. Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition.
    Abelson JL, Young EA.
    Psychoneuroendocrinology; 2003 Feb; 28(2):169-80. PubMed ID: 12510010
    [Abstract] [Full Text] [Related]

  • 38. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
    Maron E, Tõru I, Mäemets K, Sepp S, Vasar V, Shlik J, Zharkovsky A.
    J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
    [Abstract] [Full Text] [Related]

  • 39. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M, Yassouridis A, Jahn H, Wiedemann K.
    Psychopharmacology (Berl); 1997 Sep; 133(1):55-61. PubMed ID: 9335081
    [Abstract] [Full Text] [Related]

  • 40. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.